TipRanks
Go Ultimate55% OFF

aXichem AB Class A (A6X) AI Stock Analysis

DE:A6X

aXichem AB Class A

(Frankfurt:A6X)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low Financial LeverageThe modest debt burden and predominantly equity-funded asset base reduce near-term solvency pressure. This gives aXichem greater flexibility to pursue product development and commercialization while limiting the immediate drag from interest obligations and refinancing needs.
Negative Factors
Declining Revenue and Deep LossesThe combination of lower trailing revenue, negative gross profit, and an exceptionally deep net margin shows that the current business has not yet established sustainable economics. Continued losses reduce internal funding capacity and make future growth dependent on a meaningful improvement in sales and profitability.

aXichem AB Class A (A6X) vs. iShares MSCI Germany ETF (EWG)

-75%-50%-25%0%25%50%DE:A6X-42.31%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 12.22M
Dividend Yield
―
Average Volume (3M)
1,503
Price to Earnings (P/E)
-7.0
Beta (1Y)
-0.21
Revenue Growth
38.80%
EPS Growth
35.96%
Country
Germany
Employees
7
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

aXichem AB Class A Business Overview & Revenue Model

Company Description

aXichem AB is a biotechnology firm, established in 2007 and headquartered in Malmö, Sweden, that specializes in creating natural analogue compounds. The company offers aXivite, a capsaicin analogue solution designed for various dietary health applica...

aXichem AB Class A Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:A6X against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:HPOL.BSE:HPOL.B68NeutralSEK 31.74B17.5512.33%4.56%-0.82%-7.46%
SE:PCATSE:PCAT65NeutralSEK 14.87M4.56――-17.14%88.76%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SE:ORGCSE:ORGC45NeutralSEK 83.91M-1.52-176.65%―-21.95%-28.77%
SE:POLYGSE:POLYG44NeutralSEK 85.47M-19.61-1.52%―-18.26%35.77%
SE:NEXAMSE:NEXAM43NeutralSEK 258.28M-12.35-9.37%―-4.57%-15.20%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%DE:A6XSE:HPOL.BSE:NEXAMSE:POLYGSE:ORGCSE:PCATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:A6X and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:A6XaXichem AB Class A0.12-0.08-40.00%
SE:HPOL.BHexpol AB92.1511.6114.42%
SE:NEXAMNexam Chemical Holding AB2.52-0.60-19.23%
SE:POLYGPolygiene AB2.34-7.06-75.11%
SE:ORGCOrganoClick AB0.46-1.42-75.64%
SE:PCATPhotocat A/S2.48-2.32-48.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.